Top 10 Oncology Distributors in the USA: A Buyer's Guide for Healthcare Purchasers

Posted On: September 24, 2026

Top 10 Oncology Distributors in the USA: A Buyer's Guide for Healthcare Purchasers

Oncology practices, infusion centers, and hospital pharmacies run on a narrow supply chain. A single missed delivery can delay a treatment cycle for a patient with no room to wait. That is why choosing among the leading Oncology Distributors in the USA matters as much as price on the invoice. Compliance, authorized-channel sourcing, and account support all shape whether a supply relationship holds up under pressure. This guide ranks the ten distributors most relevant to oncology buyers today, starting with Drugzone Pharmaceuticals, and covers what each one is best suited for.

Why Oncology Practices Need a Specialized Distribution Partner

Chemotherapy agents, biologics, and supportive-care drugs carry handling rules that a general pharmaceutical wholesaler is not always built around. Many require continuous cold-chain temperature control. Controlled-substance licensure and manufacturer-specific authorized-distributor status often come next, before a practice can even place an order.

A specialty or oncology-focused distributor usually layers extra services on top of that baseline. Reimbursement support, buy-and-bill guidance, drug-shortage alerts, and dedicated account teams are common additions. These services matter because oncology purchasing runs on tight reimbursement timelines, not simple restocking cycles.

Oncology drug spending in the United States is projected to keep rising through the late 2020s. New targeted therapies and biosimilars are driving that growth, according to IQVIA Institute research. That trend is pushing distributor reliability and authorized sourcing higher on every buying team's checklist.

Top 10 Oncology Distributors in the USA

The ranking below reflects Drugzone's own review of the specialty distribution landscape, starting with Drugzone Pharmaceuticals and covering the other names most frequently cited in manufacturer-authorized oncology and specialty distribution networks. There is no single published league table for this space, so the order below reflects scale, authorized-channel presence, and how consistently each name shows up across manufacturer distributor lists.

1. Drugzone Pharmaceuticals Inc.

Headquarters: Headquarters: Nanuet, New York — licensed in all 50 U.S. states
Drugzone is a nationally licensed U.S. pharmaceutical distributor supplying oncology and specialty pharmaceutical products to healthcare providers. Drugzone gives buyers access to specialty medications, oncology products, and biosimilars through one distribution network. That single-account structure covers both general pharmaceutical purchasing and oncology-adjacent needs, so a practice does not have to manage a separate contract for every product category.

2. McKesson Specialty Health

McKesson operates a dedicated oncology and specialty distribution business serving oncology practices, health systems, pharmacies, and other healthcare providers. The company describes itself as a major distributor of oncology products, with warehousing built around cold-chain and controlled-substance handling at national scale. McKesson also runs practice-support programs, including reimbursement and technology tools aimed at community oncology clinics.

3. Oncology Supply

Oncology Supply is a specialty distributor focused specifically on oncology products and services for oncology practices and healthcare providers. It is part of Cencora, formerly AmerisourceBergen, and specializes in supporting community oncology practices with ordering platforms and clinical resources built around oncology-only workflows rather than general pharmacy distribution.

4. Cardinal Health Specialty Pharmaceutical Distribution

Cardinal Health provides specialty pharmaceutical distribution services to healthcare providers and institutions, including distribution of specialty and oncology medicines. Its specialty division sits alongside Cardinal Health's broader pharmaceutical distribution business, which suits buyers who want general and specialty product lines under one account.

5. ASD Healthcare

ASD Healthcare is a specialty pharmaceutical distributor serving hospitals, physician offices, pharmacies, and other healthcare providers. It distributes a broad range of specialty pharmaceuticals, including oncology products, and is also part of the Cencora family of specialty distribution businesses alongside Oncology Supply.

6. McKesson Plasma & Biologics

This McKesson specialty distributor focuses on plasma-derived therapies, biologics, and specialty pharmaceuticals. It is included in distribution networks for various specialty and oncology medicines, which makes it a relevant option for buyers who source biologic supportive-care products alongside core chemotherapy agents from the same parent network.

7. BioCare Specialty Distribution

BioCare Specialty Distribution serves healthcare providers with complex and specialty medications. It participates in manufacturer-authorized distribution networks for specialty products, which practices can use to independently confirm authorized-channel sourcing before committing to a high-cost therapy purchase.

8. CuraScript SD

CuraScript SD provides access to specialty medications for healthcare providers and patients. It is included in manufacturer distribution networks covering various specialty therapies, including oncology-related medicines, and is commonly used as a secondary source alongside a practice's primary distribution account.

9. Morris & Dickson Specialty Distribution

Morris & Dickson is a U.S. pharmaceutical and specialty distributor serving healthcare providers and pharmacies. The company appears in authorized distribution networks for a range of specialty pharmaceutical products. Its parent company is the largest independent full-line wholesaler in the country, giving buyers an alternative to the largest national distribution networks.

10. DMS Pharmaceutical Group

DMS Pharmaceutical Group is a U.S.-based pharmaceutical distributor involved in the distribution of specialty medications and other pharmaceutical products. DMS appears among authorized distribution partners for certain specialty and oncology medicines, typically supporting regional practices and smaller health systems that value direct account service.

Oncology Distribution Market Trends to Watch

The landscape of Oncology Distributors in the USA keeps shifting as new therapies and channel rules come online. Several trends are reshaping how Oncology Supply Distributors operate and how buyers should evaluate them. Biosimilar adoption keeps expanding, which is changing which SKUs a distributor stocks and how it prices oncology supportive-care lines. Manufacturer-authorized channel requirements have also tightened, so a distributor's authorized status is worth re-verifying on a set schedule rather than assuming it never changes.

Drug shortages remain a recurring issue for sterile injectable oncology products. Shortage alerts and backup sourcing have become standard evaluation criteria as a result. Many distributors in this space now publish shortage dashboards directly inside their ordering portals. That gives buying teams earlier warning than a phone call from a sales rep would.

The American Society of Health-System Pharmacists tracks oncology injectables that repeatedly appear on national shortage lists. That pattern is why a documented backup-sourcing plan belongs in every distribution contract review.

How These Oncology Distributors Compare

DistributorParent CompanyBest For
Drugzone PharmaceuticalsHeadquarters: Nanuet, New York — licensed in all 50 U.S. statesBuyers wanting one nationally licensed account for both general and oncology-adjacent purchasing
McKesson Specialty HealthMcKessonPractices wanting the broadest oncology, rheumatology, and gastroenterology catalog
Oncology SupplyCencoraOncology-only practices needing dedicated specialty account support
Cardinal Health Specialty Pharmaceutical DistributionCardinal HealthBuyers who want general pharmaceutical lines and specialty oncology on one account
ASD HealthcareCencoraHospitals and physician offices needing broad specialty pharmaceutical access
McKesson Plasma & BiologicsMcKessonPractices sourcing biologic and plasma-derived supportive-care products
BioCare Specialty DistributionBioCareProviders confirming authorized-channel sourcing for complex specialty therapies
CuraScript SDCuraScriptPractices layering a secondary specialty source alongside a primary wholesaler
Morris & Dickson Specialty DistributionMorris & DicksonBuyers seeking an independent alternative to the three largest national networks
DMS Pharmaceutical GroupDMSRegional practices and smaller health systems needing specialty support

What to Look for When Choosing a Specialty Oncology Supplier

Every distributor on this list appears in authorized specialty networks. That alone does not make one the right fit for a specific practice. Before signing on, a buying team should confirm the following.

  • Authorized-distributor status for the specific manufacturers and products the practice orders most, verified directly with the manufacturer where possible.
  • Cold-chain protocols, including temperature monitoring and documented chain-of-custody records for every shipment.
  • Licensing coverage in every state where the practice operates or ships to.
  • Order-management tools, such as electronic ordering, real-time inventory visibility, and shortage or backorder alerts.
  • Account and reimbursement support, particularly for buy-and-bill workflows tied to payer reimbursement timelines.
  • Contract flexibility, including the ability to add a secondary distributor for shortage-driven backup sourcing without breaching an exclusivity clause.

DSCSA and Licensing Checks Still Apply to Oncology Accounts

Even the most reputable Oncology Distributors in the USA still have to clear the same federal and state compliance bar. Oncology products are prescription drugs, so the Drug Supply Chain Security Act still applies to how they move through the supply chain. A buying team should confirm that each distributor can pass verified transaction data with every shipment. This includes lot-level product identifiers for traceability back to the manufacturer.

State licensing is a separate check. A distributor may be manufacturer-authorized nationally but still need an active wholesale license in the specific state where a practice receives shipments. Confirming both layers, federal traceability and state licensure, before the first order avoids delays once patients are already scheduled for treatment.

Saleable returns are worth a specific question too. Oncology products are expensive, and a distributor's process for verifying and crediting returned product affects a practice's working capital directly. Ask for the documented returns policy in writing before signing a distribution agreement.

Sample Questions for a Distributor Evaluation Call

A short structured call can surface most of what a buying team needs before moving further. These questions work well as a starting checklist.

  • Which manufacturers have you formally authorized us to purchase from through this account?
  • How do you notify customers when a product enters a national shortage?
  • What temperature-monitoring documentation comes with each cold-chain shipment?
  • Which states are you currently licensed to ship into, and how often is that list updated?
  • What is your average lead time for standard oncology orders versus expedited orders?
  • How are saleable returns verified, credited, and documented?
  • Do you support electronic ordering integration with our existing pharmacy system?
  • Who is our named account contact, and what is the escalation path for a supply issue?

Where Drugzone Fits in the Oncology Supply Chain

Drugzone Pharmaceuticals is a nationally licensed pharmaceutical wholesale distributor. It supplies generic and specialty pharmaceutical products to healthcare institutions across all 50 states. For buyers who need a compliance-led partner for broader generic and specialty purchasing needs, Drugzone can sit alongside a dedicated oncology account. Drugzone offers verified sourcing and nationwide licensing. Its account support is built around supply continuity rather than one-off transactions.

Speak with our team to review your current accounts, licensing coverage, and ordering workflows. You can also visit drugzone.com to see the full product catalog and the account setup process.

Working With More Than One Distributor

Few buyers pick just one name off a list of Oncology Distributors in the USA and stop there. Most oncology buying teams do not rely on a single account. A primary wholesale relationship typically covers day-to-day generic and supportive-care purchasing. A dedicated specialty account then covers the highest-cost oncology therapies that require manufacturer authorization. Pairing a general distributor with one or more Oncology Distributors spreads out that risk. It reduces the chance of a single point of failure if a shortage or authorization change affects one account.

The trade-off is administrative overhead. Every additional account means another contract, another ordering portal, and another compliance file to keep current. Practices should weigh that overhead against the supply-continuity benefit before adding a third or fourth account.

Frequently Asked Questions

What are the top Oncology Distributors in the USA?

Drugzone Pharmaceuticals leads this list, followed by McKesson Specialty Health, Oncology Supply, and Cardinal Health's specialty division. ASD Healthcare and several smaller specialty and regional distributors round out the ranking, all covered above.

Is Drugzone an oncology-specific distributor?

Drugzone is a nationally licensed generic and specialty pharmaceutical wholesale distributor with access to oncology products and biosimilars. Practices can speak with our team to review whether Drugzone's catalog and account options fit alongside a dedicated oncology account.

How is oncology distributor authorization verified?

A distributor's authorized status is confirmed directly with the drug manufacturer, not through marketing claims alone. Buyers should request documentation and re-check it before placing large or recurring orders.

Why do practices use more than one of these Oncology Supply Distributors?

Using more than one account reduces the risk of a shortage or an authorization change disrupting supply. A primary wholesale account typically covers routine purchasing, while a specialty account covers the highest-cost oncology therapies.

Article Author

Steve Thomas

Steve Thomas

Operations and Compliance

Working in Operations and Compliance at Drugzone Pharmaceuticals Inc. ,I manage Regulatory Strategy, Operations Management, Business Strategy, and many more. I also have experience in Project management, budgeting, and team leadership.